Company Email Format Management

Precirix

Biotechnology Research Be 39 employees

Employees: 39
Contacts: 3
Emails: 3
Phones: 1

camel-ids.com LinkedIn Crunchbase

Precirix Overview

Headquarters: Be
Website: camel-ids.com
Industry: Biotechnology Research
Employees: 39
Founded: 2014
Funding: 88.2M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnologies Targeted Radionuclide Therapy Oncology Camel derived antibodies Radiopharmaceuticals Single Domain Antibodies Actinium-225

About Precirix

PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting HER2-positive tumors, while further progressing and broadening its oncology pipeline. PRECIRIX' technology platform allows for a theranostic approach, using the same molecule for patient selection (imaging) and therapy.

Precirix Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Precirix Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christina Takke		Amsterdam, North Holland, Netherlands	Email Phone
Geert Raes	Staff Scientist at Vib - Vrije Universiteit Brussel	Brussels Metropolitan Area, Belgium	Email
Tom Plitz	CEO - Board Member		View
Wouter De Koster	Sociale Relaties;hr Manager; Verzuimmanagement	Opwijk, Flemish Region, Belgium	Email